emodin has been researched along with fluorouracil in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Atzler, K; Baqi, Y; Glänzel, M; Köse, M; Müller, CE | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Chen, YQ; Jiang, JH; Liu, JJ; Wan, LJ; Yan, ZW; Zhang, LM; Zhang, SQ; Zhao, LM | 1 |
Chiu, YF; Ko, JC; Kuo, YH; Lin, YW; Su, YC; Tsai, MS; Weng, SH | 1 |
He, A; Liu, N; Qin, G; Yang, C; Zhang, M; Zheng, X; Zu, C | 1 |
Cheng, S; Huang, L; Li, M; Li, S; Shi, J; Wang, H; Yan, H; Zou, C | 1 |
7 other study(ies) available for emodin and fluorouracil
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.
Topics: Anthraquinones; Binding, Competitive; Humans; Molecular Structure; Purinergic P2 Receptor Antagonists; Radioligand Assay; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stereoisomerism; Structure-Activity Relationship | 2009 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Emodin; Fluorouracil; Humans; Inhibitory Concentration 50 | 2012 |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine.
Topics: Antineoplastic Agents; Capecitabine; Cell Death; Cell Line, Tumor; Deoxycytidine; DNA-Binding Proteins; Drug Synergism; Emodin; Endonucleases; Fluorouracil; Gene Knockdown Techniques; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Proteasome Endopeptidase Complex; Protein Stability; Rad51 Recombinase; RNA, Messenger; Thymidine Phosphorylase | 2011 |
Low dose Emodin induces tumor senescence for boosting breast cancer chemotherapy via silencing NRARP.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Cellular Senescence; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Emodin; Female; Fluorouracil; Humans; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Neoplasm Proteins; Protein Kinase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
[Spectrum-effect relationship of total anthraquinone extract of
Topics: Animals; Anthraquinones; Antioxidants; Cassia; Chemical and Drug Induced Liver Injury, Chronic; Emodin; Fluorouracil; Mice; Plant Extracts | 2023 |